Home// - Plasma-derived therapy for C19
Are you sure you want to exit?
Any unsave changes will be lost.
Plasma-derived therapy for C19
CSL Behring
Category
Laboratory
Country
United States of America (USA), North America
Description
CSL has partnered with other pharmas to develop a potential plasma-derived therapy for treating COVID-19.